Real-time enrollment status for this small cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 6:34 PM UTC
| NCT Number | NCT07778316 |
| Recruiting Status | Recruiting |
| Condition | Small Cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 400 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Amgen |
| Last Updated on CT.gov | August 21, 2026 (1 week ago) |
As of August 31, 2026: Clinical trial NCT07778316 is currently recruiting participants. This phase3 study for small cell lung cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Amgen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07778316 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07778316 was last updated 1 week ago (August 21, 2026). HelloStudys verifies this status automatically.